Stockscreener 앱 받기
20.36
0.44%
0.09
Mbx Biosciences Inc 주식(MBX)의 최신 뉴스
MBX Biosciences (NYSE:MBX) Shares Gap DownShould You Sell? - MarketBeat
Teachers Retirement System of The State of Kentucky Makes New $694,000 Investment in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
MBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
MBX Biosciences (NYSE:MBX) Trading 4.6% HigherHere's Why - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Gap UpWhat's Next? - MarketBeat
The Manufacturers Life Insurance Company Invests $1.20 Million in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Wellington Management Group LLP Takes $74.26 Million Position in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Frazier Life Sciences Management L.P. Makes New $155.50 Million Investment in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
Maven Securities LTD Makes New $1.30 Million Investment in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
RA Capital Management L.P. Takes $39.26 Million Position in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
MBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and Metabolism - The Manila Times
MBX Biosciences Announces MBX 2109 Phase 1 Study Results - GlobeNewswire
NEA Management Company LLC Invests $93.90 Million in MBX Biosciences, Inc. (NYSE:MBX) - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Down 3.6% – Should You Sell? - Defense World
MBX Biosciences (NYSE:MBX) Shares Down 3.6%Time to Sell? - MarketBeat
MBX Biosciences (NYSE:MBX) Trading Up 6.5%Still a Buy? - MarketBeat
MBX Biosciences completes phase 1 trial of diabetes drug By Investing.com - Investing.com Canada
MBX Biosciences completes phase 1 trial of diabetes drug - Investing.com India
MBX Biosciences Announces Last Subject Last Visit in Phase - GlobeNewswire
Mbx Biosciences, Inc. Announces Last Subject Last Visit in Phase 1 Trial of Mbx 1416 for the Treatment of Post-Bariatric Hypoglycemia - Marketscreener.com
MBX Biosciences (NYSE:MBX) Reaches New 12-Month Low – Here’s Why - Defense World
MBX Biosciences (NYSE:MBX) Sets New 1-Year LowTime to Sell? - MarketBeat
MBX Biosciences: Decent Potential For Lead Indication, But Need More Data (NASDAQ:MBX) - Seeking Alpha
Behind the Bell: MBX Biosciences - Nasdaq
MBX Biosciences Reports Q3 2024 Financial Progress - MSN
Wellington Management Group LLP Acquires New Stake in MBX Biosci - GuruFocus.com
MBX Biosciences Inc. (MBX) Quarterly 10-Q Report - Quartzy
MBX Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
MBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times
MBX Biosciences Secures $251M in IPO, Advances Clinical Pipeline with Strong Cash Position | MBX Stock News - StockTitan
MBX Biosciences (NYSE:MBX) Shares Up 8.2%Time to Buy? - MarketBeat
MBX Biosciences (NYSE:MBX) Shares Up 6.8%Should You Buy? - MarketBeat
MBX Biosciences (NYSE:MBX) Sets New 52-Week LowTime to Sell? - MarketBeat
MBX Biosciences to Participate in Upcoming November Investor Conferences - The Manila Times
MBX Biosciences (NYSE:MBX) Shares Down 4.5%Here's What Happened - MarketBeat
MBX Biosciences sets IPO terms with plans to raise up to $136 million - MSN
MBX Biosciences, Inc.'s (NYSE:MBX) Quiet Period To End on October 23rd - MarketBeat
MBX Biosciences, Inc.’s Quiet Period Set To Expire on October 23rd (NYSE:MBX) - Defense World
MBX Biosciences (NYSE:MBX) Stock Price Down 4%Here's Why - MarketBeat
MBX Bio drops despite bullish views on Street - MSN
2.88%
2.65%
자본화:
|
볼륨(24시간):